Systematically evaluating read-across prediction and performance using a local validity approach characterized by chemical structure and bioactivity information

Regul Toxicol Pharmacol. 2016 Aug:79:12-24. doi: 10.1016/j.yrtph.2016.05.008. Epub 2016 May 9.

Abstract

Read-across is a popular data gap filling technique within category and analogue approaches for regulatory purposes. Acceptance of read-across remains an ongoing challenge with several efforts underway for identifying and addressing uncertainties. Here we demonstrate an algorithmic, automated approach to evaluate the utility of using in vitro bioactivity data ("bioactivity descriptors", from EPA's ToxCast program) in conjunction with chemical descriptor information to derive local validity domains (specific sets of nearest neighbors) to facilitate read-across for up to ten in vivo repeated dose toxicity study types. Over 3239 different chemical structure descriptors were generated for a set of 1778 chemicals and supplemented with the outcomes from 821 in vitro assays. The read-across prediction of toxicity for 600 chemicals with in vivo data was based on the similarity weighted endpoint outcomes of its nearest neighbors. The approach enabled a performance baseline for read-across predictions of specific study outcomes to be established. Bioactivity descriptors were often found to be more predictive of in vivo toxicity outcomes than chemical descriptors or a combination of both. This generalized read-across (GenRA) forms a first step in systemizing read-across predictions and serves as a useful component of a screening level hazard assessment for new untested chemicals.

Keywords: (Q)SAR; Bioactivity; KNN; Local validity domains; Nearest neighbors; Read-across; ToxCast.

Publication types

  • Evaluation Study

MeSH terms

  • Algorithms*
  • Animal Testing Alternatives
  • Animals
  • Biological Assay*
  • Cluster Analysis
  • Data Mining / methods*
  • Databases, Factual
  • Environmental Pollutants / chemistry*
  • Environmental Pollutants / toxicity*
  • Humans
  • Molecular Structure
  • Pattern Recognition, Automated*
  • Pharmaceutical Preparations / chemistry*
  • Quantitative Structure-Activity Relationship
  • Reproducibility of Results
  • Risk Assessment
  • Toxicity Tests / methods*

Substances

  • Environmental Pollutants
  • Pharmaceutical Preparations